日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trial

阿特珠单抗联合贝伐珠单抗一线治疗不可切除肝细胞癌:AMETHISTA IIIb期试验的中期分析结果

Piscaglia, F; Masi, G; Martinelli, E; Cabibbo, G; Di Maio, M; Gasbarrini, A; Iavarone, M; Antonuzzo, L; Mazzaferro, V; Ballestrero, A; Garufi, C; Bergamo, F; Celsa, C; Marino, D; Tovoli, F; Ponziani, F R; Pressiani, T; Astolfi, C; Gazzoli, G C; Ciardiello, F; Daniele, B; Rimassa, L

Comprehensive genomic profiling by liquid biopsy portrays metastatic colorectal cancer mutational landscape to predict antitumor efficacy of FOLFIRI plus cetuximab in the CAPRI-2 GOIM trial

通过液体活检进行全面的基因组分析,可以描绘转移性结直肠癌的突变图谱,从而预测 CAPRI-2 GOIM 试验中 FOLFIRI 联合西妥昔单抗的抗肿瘤疗效。

Ciardiello, D; Boscolo Bielo, L; Napolitano, S; Latiano, T P; De Stefano, A; Tamburini, E; Toma, I; Bordonaro, R; Russo, A E; Pisconti, S; Nisi, C; Lotesoriere, C; Vallarelli, S; Lonardi, S; Iacono, D; Cremolini, C; Tortora, G; Tagliaferri, P; Pietrantonio, F; Rosati, G; Lucenti, A; Scartozzi, M; Brunetti, O; Cinieri, S; Zampino, M G; Zaniboni, A; Berardi, R; Paoletti, G; Febbraro, A; Martinelli, E; Troiani, T; Cioli, E; Normanno, N; Di Maio, M; Parente, P; Fazio, N; Curigliano, G; De Vita, F; Avallone, A; Maiello, E; Ciardiello, F; Martini, G

Sexual health in cancer care: a narrative review and position statement from the Italian Association of Medical Oncology (AIOM)

癌症治疗中的性健康:意大利肿瘤内科学会 (AIOM) 的叙述性综述和立场声明

Rossi, A; Leone, A G; Lambertini, M; Sperti, E; Cassani, C; Vetromile, A; Barni, S; De Giorgi, A; Preti, E P; Secondino, S; Silvestris, N; Berardi, R; Brunello, A; Curigliano, G; La Verde, N; Latiano, T P; Pietrantonio, F; Tiseo, M; Di Maio, M; Perrone, F; Cinieri, S; Fabi, A

Impact of age and sex on the efficacy and safety of ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy: a subgroup analysis of the ARMANI phase III trial

年龄和性别对雷莫芦单抗联合紫杉醇作为一线奥沙利铂化疗的转换维持治疗与继续治疗的疗效和安全性的影响:ARMANI III期试验的亚组分析

Fazio, R; Randon, G; Bergamo, F; Palermo, F; Tamberi, S; Giommoni, E; Di Donato, S; Fornaro, L; Brunetti, O; De Vita, F; Valgiusti, M; Gobba, S M; Spallanzani, A; Murgioni, S; Bethaz, V; Strippoli, A; Latiano, T P; Cardellino, G G; Ceccon, C; Raimondi, A; Prisciandaro, M; Pircher, C C; Ambrosini, M; Manca, P; Fassan, M; Di Bartolomeo, M; Di Maio, M; Pietrantonio, F

Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET)

非功能性晚期胃肠胰神经内分泌肿瘤管理临床实践指南:采用 GRADE 方法进行证据评估和建议,由意大利肿瘤内科学会 (AIOM) 与意大利神经内分泌肿瘤协会 (ITANET) 合作制定。

Spada, F; Gelsomino, F; Rinzivillo, M; Cinquini, M; Fittipaldo, V A; Tralongo, A; Moschetti, I; Albertelli, M; Ambrosini, V; Amoroso, V; Antonuzzo, L; Badalamenti, G; Bajetta, E; Baldari, S; Barberis, M; Berruti, A; Bertani, E; Bonomo, G; Bodei, L; Buzzoni, R; Brizzi, M P; Campana, D; Capurso, G; Casadei, R; Castellano, M; Cingarlini, S; Cives, M; Colao, A M; Coppa, J; Cremonini, N; Davì, M V; De Angelis, C G; de Braud, F; De Robertis, R; Faggiano, A; Falconi, M; Fassan, M; Ferolla, P; Ferone, D; Filice, A; Fiore, F; Funicelli, L; Granata, V; Giuffrida, D; Grana, C M; Grimaldi, F; Ibrahim, T; La Salvia, A; Laghi, A; Luppi, G; Maccauro, M; Marconcini, R; Massironi, S; Mazzaferro, V; Merola, E; Milione, M; Modica, R; Ortolani, S; Papotti, M G; Partelli, S; Pelosi, G; Pusceddu, S; Ramundo, V; Ravizza, D; Razzore, P; Reimondo, G; Ricci, C; Rindi, G; Rizzo, F M; Rossi, R E; Tafuto, S; Tiberio, G A M; Versari, A; Vigorito, R; Zatelli, M C; Di Maio, M; Perrone, F; Cinieri, S; Panzuto, F; Fazio, N

Integration of translational research in phase III trials: A systematic review of breast cancer studies in a 5-year period

将转化研究整合到 III 期临床试验中:一项针对五年内乳腺癌研究的系统性综述

Giannone, G; Lombardi, P; Filetti, M; Paparo, J; Rognone, C; Stefanizzi, S; Valsecchi, A A; Zumstein, L; McNeish, I A; Pinato, D J; Gennari, A; Daniele, G; Di Maio, M

Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials

主观症状报告不足及其预后价值:12项癌症临床试验的汇总分析

Arenare, L; Di Liello, R; De Placido, P; Gridelli, C; Morabito, A; Pignata, S; Nuzzo, F; Avallone, A; Maiello, E; Gargiulo, P; Schettino, C; Gravina, A; Gallo, C; Chiodini, P; Di Maio, M; Perrone, F; Piccirillo, M C

Predicting early recurrence after resection of initially unresectable colorectal liver metastases: the role of baseline and pre-surgery clinical, radiological and molecular factors in a real-life multicentre experience

预测最初无法切除的结直肠肝转移瘤切除术后的早期复发:基线和术前临床、影像学和分子因素在真实世界多中心研究中的作用

Moretto, R; Germani, M M; Borelli, B; Conca, V; Rossini, D; Boraschi, P; Donati, F; Urbani, L; Lonardi, S; Bergamo, F; Cerma, K; Ramondo, G; D'Amico, F E; Salvatore, L; Valente, G; Barbaro, B; Giuliante, F; Di Maio, M; Masi, G; Cremolini, C

Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies

前列腺癌患者的骨骼健康和身体成分:泌尿外科协会 (URO) 和美国骨科医学会 (AIOM) 关于预防和管理策略的共识

Cursano, M C; Valsecchi, A A; Pantano, F; Di Maio, M; Procopio, G; Berruti, A; Bertoldo, F; Tucci, M; De Giorgi, U; Santini, D

Association between health-related quality-of-life results, outcomes of efficacy and drug approvals: a meta-research study of randomized phase III trials in oncology

健康相关生活质量结果、疗效结果和药物审批之间的关联:一项肿瘤学随机III期试验的荟萃研究

Paratore, C; Zichi, C; Schiavone, R; Caglio, A; Gamba, T; Bombaci, S; Vellani, G; Marandino, L; Perrone, F; Di Maio, M